SCHEMBL20141891

SCHEMBL20141891

N#Cc1ccc(Nc2nc(N)c(C(=O)c3ccc(Cl)cc3)s2)cc1

nearest known ligand 0.80

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.80
GSK3B P49841 2/20 0.80
CCNA2 P20248 9/20 0.69
CDK2 P24941 9/20 0.69
CDK5 Q00535 7/20 0.62
CDK5R1 Q15078 7/20 0.62
NPC1 O15118 3/20 0.61
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
MAPT P10636 4/20 0.59
RAB9A P51151 1/20 0.59
MAPK14 Q16539 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.58
LMNA P02545 2/20 0.56
TP53 P04637 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20141893 1.00 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142463 0.94 GSK3A (0.89) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL4398263 0.91 CDK5 (0.72) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142196 0.90 GSK3A (0.81) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142290 0.89 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142449 0.89 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142458 0.89 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142068 0.89 GSK3A (1.00) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL25609556 0.88 GSK3A (0.79) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142357 0.88 GSK3A (0.79) GSK3AGSK3BCCNA2CDK2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO claimed
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO disclosed